                         SEQUENCE LISTING

<110>  Athos Therapeutics, Inc.
 
<120>  EX VIVO GASTROINTESTINAL BIOPSY PLATFORM TO EVALUATE MULTI-OMIC 
       SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS

<130>  ATHO.005WO

<150>  63/062954
<151>  2020-08-07

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  DNA
<213>  Synthetic


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  5-methylcytosine

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  5-methylcytosine

<220>
<221>  misc_feature
<222>  (14)..(14)
<223>  5-methylcytosine

<400>  1
ctgctgaact gagcca                                                       16


<210>  2
<211>  16
<212>  DNA
<213>  Synthetic

<400>  2
ctgctgaact gagcca                                                       16


<210>  3
<211>  16
<212>  DNA
<213>  Synthetic


<220>
<221>  misc_feature
<223>  miR-24-A

<220>
<221>  misc
<222>  (1)..(16)
<223>  phosphorothioate linkages

<220>
<221>  misc
<222>  (1)..(3)
<223>  Locked Nucleic Acids

<220>
<221>  misc
<222>  (4)..(4)
<223>  5-methylcytosine

<220>
<221>  misc
<222>  (9)..(9)
<223>  5-methylcytosine

<220>
<221>  misc
<222>  (10)..(11)
<223>  Locked Nucleic Acids

<220>
<221>  misc
<222>  (14)..(14)
<223>  5-methylcytosine

<220>
<221>  misc
<222>  (15)..(16)
<223>  Locked Nucleic Acids

<400>  3
ctgctgaact gagcca                                                       16


<210>  4
<211>  16
<212>  DNA
<213>  Synthetic


<220>
<221>  misc_feature
<223>  miR-24-B

<220>
<221>  misc_feature
<222>  (1)..(16)
<223>  phosphorothioate linkages

<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Locked Nucleic Acid

<220>
<221>  misc_feature
<222>  (14)..(16)
<223>  Locked Nucleic Acid

<400>  4
ctgctgaact gagcca                                                       16


